智通财经APP讯，达安基因(002030.SZ)发布公告，近日，公司取得国家药品监督管理局颁发的医疗器械注册证一个，该医疗器械为：季节性流感病毒H3亚型核酸检测试剂盒(PCR-荧光探针法)，注册证编号：国械注准20253400060。有效期自批准之日起至2030年1月9日。预期用途：本试剂盒适用于定性检测人口咽拭子样本中季节性流感病毒H3亚型(IVAH3)RNA。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.